Email updates

Keep up to date with the latest news and content from BMC Surgery and BioMed Central.

Open Access Study protocol

Sleep study, respiratory mechanics, chemosensitive response and quality of life in morbidly obese patients undergoing bariatric surgery: a prospective, randomized, controlled trial

Luis VF Oliveira1*, Isabella C Aguiar1, Raquel P Hirata1, Newton S Faria Junior1, Israel S Reis2, Luciana MM Sampaio1, Claudia S Oliveira1, Paulo TC Carvalho1, Fernando SS Leitao Filho3, Lilian C Giannasi2, Lia Azevedo Pinto4, Carlos Alberto Malheiros5 and Wilson Rodrigues Freitas5

Author affiliations

1 Master's and Doctoral Degree Program in Rehabilitation Sciences, Nove de Julho University, Sao Paulo, Brazil

2 Sleep Laboratory, Nove de Julho University, Sao Paulo, Brazil

3 School of Medicine, Fortaleza University, Fortaleza, Ceara, Brazil

4 Psychology Service, Santa Casa de Misericórdia Hospital, Sao Paulo, Brazil

5 Surgery Department, Santa Casa de Misericórdia Hospital, Sao Paulo, Brazil

For all author emails, please log on.

Citation and License

BMC Surgery 2011, 11:28  doi:10.1186/1471-2482-11-28

The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2482/11/28


Received:2 August 2011
Accepted:17 October 2011
Published:17 October 2011

© 2011 Oliveira et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Obesity is a major public health problem in both developed and developing countries alike and leads to a series of changes in respiratory physiology. There is a strong correlation between obesity and cardiopulmonary sleep disorders. Weight loss among such patients leads to a reduction in these alterations in respiratory physiology, but clinical treatment is not effective for a long period of time. Thus, bariatric surgery is a viable option.

Methods/Design

The present study involves patients with morbid obesity (BMI of 40 kg/m2 or 35 kg/m2 to 39.9 kg/m2 with comorbidities), candidates for bariatric surgery, screened at the Santa Casa de Misericórdia Hospital in the city of Sao Paulo (Brazil). The inclusion criteria are grade III morbid obesity, an indication for bariatric surgery, agreement to participate in the study and a signed term of informed consent. The exclusion criteria are BMI above 55 kg/m2, clinically significant or unstable mental health concerns, an unrealistic postoperative target weight and/or unrealistic expectations of surgical treatment. Bariatric surgery candidates who meet the inclusion criteria will be referred to Santa Casa de Misericórdia Hospital and will be reviewed again 30, 90 and 360 days following surgery. Data collection will involve patient records, personal data collection, objective assessment of HR, BP, neck circumference, chest and abdomen, collection and analysis of clinical preoperative findings, polysomnography, pulmonary function test and a questionnaire on sleepiness.

Discussion

This paper describes a randomised controlled trial of morbidly obese patients. Polysomnography, respiratory mechanics, chemosensitive response and quality of life will be assessed in patients undergoing or not undergoing bariatric surgery.

Trial Registration

The protocol for this study is registered with the Brazilian Registry of Clinical Trials - ReBEC (RBR-9k9hhv).

Background

Obesity is currently one of the most serious public health problems. The prevalence of this condition has grown in an accentuated fashion in recent decades, even in developing countries, leading to a global epidemic. Over 1.6 billion adults worldwide are overweight, among which 400 million are obese. The World Health Organisation predicts that 10% of the global population will be obese by 2015 [1]. As poverty has been undergoing a process of eradication, obesity has become a more frequent and more serious problem than malnutrition [2,3]. In adults, overweight is characterised by a body mass index (BMI) between 25 kg/m2 and 29.9 kg/m2 and obesity is defined beginning at 30 kg/m2 [4].

When excess weight reaches very high values (BMI ≥ 40 kg/m2), obesity is considered a severe dysfunction due to the association with diseases that are either caused or aggravated by this condition, corresponding to grade III obesity, which is also denominated morbid obesity [4]. The most frequent comorbidities are systemic arterial hypertension [5,6], type II diabetes mellitus [7], obstructive sleep apnoea [8], degenerative joint disease [9], dyslipidemia, coronary disease [10,11], respiratory dysfunction [12] and psychosocial problems [13].

Obesity is the most important risk factor for obstructive sleep apnoea (OSA), especially with fat build-up in the upper portion of the abdomen and the neck region. At least 60 to 70% of patients with OSA are obese [14]. Moreover, the incidence among patients with Grade III obesity is 12-fold to 30-fold greater than that in the general population [15,16]. OSA is characterised by recurrent episodes of partial or complete obstruction of the upper airway during sleep in the presence of ventilatory effort, with a consequent drop in oxyhemoglobin saturation, generating negative intrathoracic pressure and arousals [17]. The gold standard for the diagnosis of OSA is basal nocturnal polysomnography (PSG), which is the simultaneous recording of physiological parameters during a night of sleep, involving the analysis of sleep stages, breathing pattern, cardiovascular function and body movements [18,19].

The association between obesity and respiratory sleep disorders was first described in 1918 by William Osler, who was reminded of a Charles Dickens' characters nicknamed "John, the fat boy", a plethoric snorer and terribly sleepy [20]. The treatment of obesity in these patients has since become a priority [21]. Common diseases such as obesity and hypertension should not be analysed without considering respiratory sleep disorder as a possible causal factor. In recent years, the prevalence of such disorders has grown, affecting 40% of the general population [22,23].

The aim of the treatment of obesity is to improve both health and quality of life through enough of a reduction in body weight to eliminate or improve comorbidities and promote psychological wellbeing [24]. Medical management of obesity is routinely the first line of treatment prescribed by physicians and lay persons alike. Medical therapy often involves a combination of calorie restriction, behaviour modification, increased exercise and pharmacotherapy. Behaviour modification in the treatment regimen may help slow the tendency toward weight regain, but does not prevent it entirely. Unfortunately, the medical treatment of morbid obesity provides minimal sustained weight loss in the majority of patients [25,26]. The fact that morbid obesity remains largely refractory to dietary and medication therapy makes bariatric surgery a viable option [27].

Patients with a BMI of greater than 40 Kg/m2 or 35 to 39.9 Kg/m2 and associated to comorbidities are candidates for bariatric surgery. The most often employed surgical methods are divided into three groups: restrictive, malabsorptive and mixed [28,29]. The most common techniques are Fobi-Capella surgery and Scopinaro's biliopancreatic diversion, which are mixed techniques [30].

This study will sleep study, respiratory mechanics, chemosensitive response and quality of life in morbidly obese patients undergoing bariatric surgery.

Aims and hypotheses

The aims of this study are to assess the evolution of pulmonary function through spirometry, ventilatory mechanics and breathing tests as well as sleep study parameters and quality of life in subjects suffering from morbid obesity undergoing bariatric surgery and determine a possible correlation between weight loss and these physiological variables. We hypothesise that the weight loss induced by surgical intervention reduces the impact of this disease on sleep quality, cardiovascular consequences and quality of life as well as financial expenditures on treatment.

Methods/design

Study design

The study design is a parallel-group randomised controlled trial and is summarised in Figure 1, and is being conducted according to the ethical standards established in the 1961 Declaration of Helsinki (as revised in Hong Kong in 1989 and in Edimburgh, Scotland in 2000). This study is registered with the World Health Organization Universal Trial Number (UTN) U1111-1121-8873, and Registro Brasileiro de Ensaios Clínicos (RBR-9k9hhv), and has been approved by the Human Research Ethics Committees of the Nove de Julho University, São Paulo, Brazil (process number 220506/2009). All participants gave written, informed consent.

thumbnailFigure 1. Flowchart representing the study design.

Subjects and recruitment procedure

Individuals with morbid obesity (BMI between 40 kg/m2 and 50 Kg/m2) or BMI between 35 kg/m2 and 39.9 kg/m2 associated to comorbidities will be recruited from the surgery ward of the Santa Casa de Misericórdia Hospital of the city of Sao Paulo (Brazil) and sent to the Sleep Laboratory of the Universidade Nove de Julho, Sao Paulo (Brazil). Participants will be recruited consecutively and screened for eligibility using a standardised protocol. The eligibility criteria are described below.

Inclusion Criteria

1- Grade III morbid obesity (BMI ≥ 40 kg/m2) or ≥ 35 kg/m2 with comorbidities;

2- Male and female patients aged 18 to 65 years;

3- Documented history of conventional weight loss attempts having proven unsuccessful over time;

4- Agreement to participate in the study through a signed term of informed consent.

Exclusion Criteria

1- Any medical condition rendering surgery too risky;

2- BMI above 55 kg/m2;

3- Clinically significant or unstable mental health concerns;

4- Unrealistic postoperative target weight and/or unrealistic expectations of surgical treatment;

5- Pregnancy, lactation or planned pregnancy within two years of potential surgical treatment;

6- Lack of safe access to abdominal cavity or gastrointestinal tract;

7- Smoking (at least 8 weeks prior to surgery), abusive alcohol use or drug use.

Randomisation

Following the initial evaluation and fulfilment of the eligibility criteria, the subjects will be randomly distributed into an intervention group [bariatric surgery group (BSG)] and control group (CG). Randomisation numbers will be generated using a randomisation table at a central office. A series of numbered, sealed, opaque envelopes will be used to ensure confidentiality. Each envelope will contain a card stipulating to which group the subject will be allocated. This randomisation criterion will be used due to the enormous number of candidates for bariatric surgery and the limited capacity of the surgical ward to meet this demand. All subjects submitted to this randomisation protocol will meet the eligibility criteria and will be clinically stable.

Sample size

A previous study published by Lettieri et al. (2008) [31] identified a mean reduction in the Apnoea-Hypnoea Index of 23.4 events/hour in morbidly obese patients submitted to bariatric surgery (expected size effect). Using a standard deviation of 22.8 events/hour from the same study and considering α = 0.05 and power = 80%, the sample was estimated as 17 patients.

Study interventions

Evaluation

All evaluations will occur prior to the surgical intervention. The patients submitted to bariatric surgery will be evaluated again 30, 90 and 360 days following the procedure. All subjects in both groups will be submitted to the following evaluation protocol.

Clinical evaluation

General physical measurements and PSG will be performed a week prior to preparation for the surgery by a well-trained physician and physical therapist following recommended procedures and using precise instruments and will include body weight (kg), height (m), calculation of body mass index (BMI) using the formula weight/height2 [32], circumferences (cm) of the neck, waist, and hip [33], heart and respiratory rates, blood pressure values, Mallampati index [34], tonsil index [35], the administration of specific questionnaires for sleep apnoea and excessive daytime sleepiness [36] and a quality of life questionnaire [37].

Educational and psychological program

During the initial evaluations, all patients will take part in an educational program in the auditorium of Santa Casa de Misericordia Hospital, where they will receive information on the development and progression of obesity, treatment (pharmacological and non-pharmacological) and the importance of regular physical activity practice. All patients will receive a chart containing the educational program [38].

Waist and neck circumference

The measurements of waist and neck circumference will be performed with a metric tape (7 mm in width). The sites of the measurements will be standardized. Waist circumference will be measured at the mid point between the lower edge of the last rib and the iliac crest. Neck circumference will be measured horizontally over the cricoid cartilage [39].

Thorax and abdomen cirtometry

Cervical thoracoabdominal cirtometry will be carried out to assess thorax and abdomen mobility and define the diaphragm index. The measurement will be performed by fixing the zero point on the metric tape to the anterior region of the thorax at the level that is being measured (axillary, xiphoid or abdominal), with the tape enveloping the entire thorax or abdomen with maximal possible pressure and the other extremity of the tape placed over this same fixed point. The aim of the maximal possible pressure of the tape on the body is to avoid the interference of soft structures in the measurements. Mobility and range of motion are provided by maximal inspiration and expiration [40].

Pulmonary function tests

Spirometry

The lung function tests will be carried out with the patient seated in a comfortable position using the KoKo PFT System Version 4.11 (nSpire Health, Inc; Louisville, CO, USA) and following guidelines for the execution of pulmonary function tests of the Brazilian Society of Pneumology [41] and the European Respiratory Society [42]. The subjects will perform the test seated as comfortably as possible, with the body erect and the upper limbs unsupported. All exams will be carried out by a technician trained in obtaining the necessary cooperation from the subjects and appropriately operating the equipment in order to ensure accurate, reproducible results. The equipment will be calibrated prior to each exam with a 3-L syringe [41].

Analysis of respiratory mechanics

Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) physiologically constitute the most adequate test for the determination of respiratory muscle strength. MIP is an indicator of ventilatory capacity and the development of respiratory failure and is indicated for the assessment of the degree of abnormality and monitoring of the weakening of inspiratory muscles individually in the progress of patients [43]. The tests will occur on the same day in which the patients undergo spirometry. The tests will be performed in a quiet setting. The patients will be seated comfortably, with the trunk at a 90-degree angle in relation to the thighs and breathing calmly and at rest [41].

Rebreathing test

In this study protocol, we will employ the re-inhalation method described by Read [44]. This is a simple technique that has been validated in the literature and allows the determination of the ventilatory response to CO2 stimulus. The patients will breathe through a mouthpiece and, after achieving a steady state, basal ventilation will be recorded for three minutes. The patients will then breathe connected to a 15-L latex balloon filled with a 7% CO2 and 93% O2 mixture for five minutes or until an end-tidal CO2 pressure (PetCO2) of 70 mm Hg is reached or until exhaustion. Data will be collected using a spirometer. The slope of ventilatory response to carbon dioxide will be obtained from a linear regression between ventilation and PetCO2. The data will be adjusted by a 0.9 correction factor to correct flow readings for hyperoxic gas mixture. The rebreathing tests will be carried out at Santa Casa de Misericordia Hospital (Sao Paulo, Brazil). All manoeuvres will be carried out by physicians.

Epworth Sleepiness Scale

The Epworth Sleep Scale is a simple, self-administered questionnaire with items addressing situations of daily activities and the occurrence of daytime sleepiness in adults. The subjects will be instructed to classify their likelihood of feeling the desire to nap or sleep in eight situations on a scale of 0 to 3 (0 = no chance of napping; 1 = small chancing of napping; 2 = moderate chance of napping; and 3 = strong chance of napping) [45,46].

Berlin Questionnaire

The Berlin Questionnaire is used to identify patients at high risk for sleep disordered breathing in a variety of populations. This clinical history questionnaire has recognized efficacy in distinguishing individuals at greater risk for OSA, with ten items organized into three categories: snoring and apnoea (5 items), daytime sleepiness (4 items), systemic arterial hypertension and obesity (1 item). Any marked response is considered positive. The score is divided into categories. Category 1 is considered positive when there are two or more positive responses to Items 1 to 5. Category 2 is considered positive when there are two or more positive responses to Items 6 to 8. Category 3 is considered positive when the response to Item 9 is "yes" or at BMI equal to or greater than 30 kg/m2. Two or more positive categories indicate high risk [47].

Polysomnography

A complete full-night PSG will be performed using a digital system (Embla, A10 version 3.1.2 Flaga, Hs. Medical Devices, Iceland) at the Sleep Laboratory of Universidade Nove de Julho. All recording sensors will be attached to the patient in a non-invasive manner using tape or elastic bands. The following physiological variables will be monitored simultaneously and continuously: four channels for the electroencephalogram (EEG) (C3-A2, C4-A1, O1-A2, O2-A1), two channels for the electrooculogram (EOG) (EOG-Left-A2, EOG-Right-A1), four channels for the surface electromyogram (muscles of the submentonian region, anterior tibialis muscle, masseter region and seventh intercostal space), one channel for an electrocardiogram (derivation V1 modified), airflow detection via two channels through a thermocouple (one channel) and nasal pressure (one channel), respiratory effort of the thorax (one channel) and the abdomen (one channel) via x-trace belts, snoring (one channel) and body position (one channel) via EMBLA sensors, and arterial oxygen saturation (SaO2) and pulse rate via an EMBLA oximeter. All PSGs will be performed and sleep stages visually scored according to standardized criteria for investigating sleep [48,49]. EEG arousals, sleep-related respiratory events and leg movements will be scored in accordance with the criteria established by the American Academy of Sleep Medicine Manual for Scoring Sleep and Associated Events [50].

The patients will be instructed to remain as relaxed as possible and sleep naturally, as if at home. All signals will be recorded continuously. Throughout the night, the subjects will be monitored by a technician experienced in polysomnography [49].

Bariatric surgery

Bariatric surgery will be performed on the subjects selected for the procedure at the Santa Casa de Misericórdia Hospital by experienced specialists. The surgical techniques employed for the treatment of obesity are divided into restrictive, malabsorptive and mixed. The aim of restrictive techniques (vertical gastroplasty with banding or Mason's surgery, adjustable gastric band) is to reduce gastric capacity in order to promote early satiety, thereby reducing the volume of food ingested. The aim of malabsorptive techniques (jejunoileal bypass or Payne's operation) is to reduce the absorption of foods through the exclusion of a segment of small intestine. Mixed techniques [Fobi-Capella surgery, Scopinaro's biliopancreatic diversion, and a Scopinaro technique modified by Marceau and Biron (duodenal-switch)] combine mechanical restriction to the food bolus and intestinal malabsorption [51,52].

Bariatric Analysis and Reporting Outcome System (Baros)

The Bariatric Analysis and Reporting Outcome System (BAROS) introduced by Oria and Moorhead in 1997 [53] provides a standard for comparisons of surgical treatment in patients with morbid obesity. This system adds or subtracts points in the evaluation of three main areas (percentage of excess weight loss, changes in medical conditions and assessment of quality-of-life), considering four outcome groups (failure, fair, good and excellent). Points are deducted for complications and reoperative surgery. The comorbidities taken into account by BAROS are hypertension, cardiovascular disease, dyslipidemia, type 2 diabetes, sleep apnoea syndrome, osteoarthritis and infertility. Idiopathic intracranial hypertension, lower extremity venous stasis disease, gastroesophageal reflux and urinary stress incontinence become comorbidities when these conditions impair or diminish quality of life or require long-tem treatment [54].

Quality control

In order to ensure data quality, the physiotherapists and physicians in charge of the data acquisition in this study will receive specific training. Periodic external monitoring will be performed to verify the adequate application of the methodology in collecting information and performing the different examinations. The results of the preoperative and postoperative exams will be analysed by blinded evaluators.

Statistical analysis

Data will be presented as means ± standard deviation, when applicable. For comparison of continuous variables before and after bariatric surgery, it will be used the paired Student t-test or Wilcoxon tests as appropriate. Comparisons between groups will be performed using Student t test or Mann-Whitney U according to the distribution.

All tests will be 2 tailed, and p values of less than 0.05 will be assumed to represent statistical significance. Multivariate linear regression will be used to identify independent predictors of the AHI following surgical weight loss. All analyses will be done using SPSS ver. 16.0 [55].

Discussion

Obesity is a chronic and often a life-long disease. It is a major cause of preventable death and is associated with a range of negative physiological and psychological consequences [56]. The aim of this study is to analyse clinical parameters referring to anthropometric data, pulmonary function tests, respiratory mechanics, sleep study, sleepiness scale and chemosensitive response to CO2 in patients with morbid obesity submitted to bariatric surgery. If successful, this project will help reduce the negative health, economic and social consequences of obesity.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

All the authors contributed to the conception and design the study. LVFO and ICA provided the idea for the study, established the hypothesis and wrote the original proposal. ICA and LVFO significantly contributed to writing this paper, while LCG, LMMS, LAP, CSO, FSSLF, RPH, ISR, CAM, WRFJ and NSFJ were involved in critically revising the manuscript. This protocol paper was written by ICA and LVFO with input from all co-authors. All authors read and approved the final manuscript.

Acknowledgements

The Sleep Laboratory receives funding from the Nove de Julho University (Brazil) and research projects approved by the Brazilian fostering agency Conselho Nacional de Desenvolvimento Científico e Tecnológico (Domestic Grants/Universal Notice MCT/CNPQ14/2008, process N° 481169/2008-3) and Fundaçao de Amparo a Pesquisa do Estado de Sao Paulo (local acronym FAPESP) (protocol number 2003/01810-4). LVFO receive grant from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (local acronym CNPq) (Research Productivity modality - PQID, process number 307618/2010-2).

References

  1. World Health Organization Obesity and overweight. Fact Sheet No 311 [http://www.who.int/mediacentre/factsheets/fs311/en/index.html] webcite

    Updated Sep 2006. Accessed 2011 May 18.

  2. Xavier MAF, Ceneviva R, Terra Filho J, Sankarankutty AK: Pulmonary function and quality of life in patients with morbid obesity six months after bariatric surgery.

    Acta cirurgica brasileira 2010, 25(5):407-415. PubMed Abstract | Publisher Full Text OpenURL

  3. Zammit C, Liddicoat H, Moonsie I, Makker H: Obesity and respiratory disease.

    International Journal of General Medicine 2010, 3:335-343. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  4. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report: National Institutes of Health

    Obes Res 1998, (Suppl 2):51S-209S. OpenURL

  5. Nieto FJ, Young TB, Lind E, Samet JM, Redline S, D'Agostinho RB, Newman AB, Lebowitz MD, Pickering TG: Association of sleepdisordered breathing, sleep apnea and hypertension in a large community-based study: Sleep Heart Health Study.

    JAMA 2000, 12(283):1829-1836. OpenURL

  6. Drager LF, Bortolotto LA, Krieger EM, Lorenzi-Filho G: Additive Effects of Obstructive Sleep Apnea and Hypertension on Early Markers of Carotid Atherosclerosis.

    Hipertension 2008, 53:64-69. Publisher Full Text OpenURL

  7. Kanaley JA, Goulopoulou SH, Franklin RM, Baynard T, Holmstrup ME, Carhart R Jr, Weinstock RS, Fernahall B: Plasticity of heart rate signaling and complexity with exercise training in obese individuals with and without type 2 diabetes.

    In J Obes (Lond) 2009, 33(10):1198-206. Publisher Full Text OpenURL

  8. Young T, Peppard PE, Taheri S: Excess weight and sleep-disordered breathing.

    J Appl Physiol 2005, 99:1592-1599. PubMed Abstract | Publisher Full Text OpenURL

  9. Beyerlein A, Von Kries R, Ness AR, Ong KK: Genetic markers of obesity risk: strong associations with body composition in overweight compared to normal-weight children.

    Plos one 2011, 6(4):19057. Publisher Full Text OpenURL

  10. Alan I, Lewis MJ, Lewis KE, Stephens JW, Baxter JN: Influence of bariatric surgery on indices of cardiac autonomic control.

    Autonomic Neuroscience: Basic and Clinical 2009, 151:168-173. Publisher Full Text OpenURL

  11. Peker Y, Hedner J, Kraiczi H, Loth S: Respiratory disturbance index: an independent predictor of mortality in coronary artery disease.

    Am J Respir Crit Care Med 2000, 162:81-86. PubMed Abstract | Publisher Full Text OpenURL

  12. Lazarus R, Sparrow D, Weiss TS: Effects of Obesity and Fat Distribution on Ventilatory Function: the normative aging study.

    Chest 1997, 111:891-98. PubMed Abstract | Publisher Full Text OpenURL

  13. Blake C, Fabick KM, Seychell KDR, Lund TD, Lephart ED: Neuromodulation by soy dietsor equol: Anti-depressive e anti-obesity-like influences, age e hormone-dependent effects.

    BMC neurosciences 2011, 12(28):1471-2202. OpenURL

  14. Stephen W, Littleton MD, Babak M: The Pickwickian Syndrome - Obesity Hipoventilation Syndrome.

    Clin Chest Med 2009, 30:467-478. PubMed Abstract | Publisher Full Text OpenURL

  15. Berger KI, Ayappa I, Chart-amontri B, Marfatia A, Sorkin IB, Rapoport DM, Goldring RM: Obesity Hypoventilation Syndrome as a Spectrum of Respiratory Disturbances During Sleep.

    Chest 2001, 120(4):1231-1238. PubMed Abstract | Publisher Full Text OpenURL

  16. Weitzenblum E, Kessler R, Chaouat A: Alveolar hypoventilation in the obese: the obesity-hypoventilation syndrome.

    Rev Pneumol Clin 2002, 58(2):83-90. PubMed Abstract | Publisher Full Text OpenURL

  17. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force

    Sleep 1999, 22:667-689. PubMed Abstract OpenURL

  18. Feinsilver SH: Current and future methodology for monitoring sleep.

    Clinics in Chest Medicine 1998, 19(1):213-18. PubMed Abstract | Publisher Full Text OpenURL

  19. Bard MS: Pathophysiology of upper airway obstruction durion sleep.

    Clinics in Chest Medicine 1998., 9(1) OpenURL

  20. Bruwell CS, Robin ED, Whaley RD: Extreme obesity associated with alveolar hipoventilation: a pickwickian syndrome.

    American Journal Medicine 1956, 21:811-818. Publisher Full Text OpenURL

  21. Namyslowski G, Scierski W, Mirowka-kata K, Kawecka I, Kawecki D, Czecior E: Sleep Study in Patients With Overweight and Obesity.

    Jornal of Physiology and Pharmacology 2005, 56(6):59-65. OpenURL

  22. Matlhota A, White DP: Obstructive sleep apnea.

    The Lancet 2002, 360(20):237-45. OpenURL

  23. Sue DY: Obesity and Pulmonary Function.

    Chest 1997, 111:844-45. PubMed Abstract | Publisher Full Text OpenURL

  24. Poirier P, Giles TD, Bray GA, Hong Y, Stern J, Pi-Sunyer FX, Eckel RH: Obesity and cardiovascular Disease: Pathophysiology, Evaluation and Effect of Weight Loss.

    Circulation 2006, 113:898-918. PubMed Abstract | Publisher Full Text OpenURL

  25. Buchwald H: Consensus conference statement bariatric surgery for morbid obesity: health implications for patients health profissionals and third-party payers.

    Surgery for obesity and related diseases 2005, 1(3):371-81. PubMed Abstract | Publisher Full Text OpenURL

  26. Yanovski SZ, Yanoviski JA: Obesity.

    N Engl J Med 2002, 346(8):591-602. PubMed Abstract | Publisher Full Text OpenURL

  27. Ceneviva R, Silva GA, Veigas MM, Sankarankutty AK, Chueire FB: Cirurgia bariátrica e apnéia do sono.

    Rev Hosp Clin Fac Med Univ São Paulo 2006, 39(2):235. OpenURL

  28. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K: Bariatric Surgery A systematic review and meta-analysis.

    JAMA 2004, 292(14):1724-1737. PubMed Abstract | Publisher Full Text OpenURL

  29. Surgical Management of Morbid Obesity

    Curr Probl Surg 2008, 45:68-137. PubMed Abstract | Publisher Full Text OpenURL

  30. Zilberstein B, Galvão NM, Ramos AC: The surgery in the obesity treatment.

    Revista Brasileira de Medicina 2002, 59(4):258-64. OpenURL

  31. Littieri CJ, Eliasson AH, Greenburg DL: Persistence of obstructive apnea after surgical weight loss.

    J Clin Sleep Med 2008, 4(4):333-338. PubMed Abstract | PubMed Central Full Text OpenURL

  32. Punjabi NM: The epidemiology of adult obstructive sleep apnea.

    Proc Am Thorac Soc 2008, 5:136-143. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  33. Dement WC: The study of human sleep: a historical perspective.

    Thorax 1998, 53(3):2-7. OpenURL

  34. Liistro G, Rombaux PH, Belge C, Dury M, Aubert G, Rodenstein DO: High mallampati score and nasal obstruction are associated risk factors for obstructive sleep apnoea.

    Eur Respir J 2003, 21:248-252. PubMed Abstract | Publisher Full Text OpenURL

  35. Nakata S, Noda A, Yanagi E, Suzuki K, Yamamoto H, Nakashima T: Tonsil size and body index are importante factors for efficacy of simple tonsillectomy in obstructive apnoea syndrome.

    Clinical Otolaryngology 2006, 31:41-45. PubMed Abstract | Publisher Full Text OpenURL

  36. Silva RS, Tufik S, Conway SG, Taddei JA, Bittencourt LRA: Sao Paulo epidemiologic study: rationale, design, sampling, and procedures.

    Sleep Medicine 2008, 10:679-685. OpenURL

  37. Moorehead MK, Ardelt-Gattinger E, Lechner H, Oria HE: The validation of Moorehead - Ardelt quality of life questionnaire II.

    Obesity Surgery 2003, 13:684-692. PubMed Abstract | Publisher Full Text OpenURL

  38. Heyward VH: Advanced fitness assessment & exercise prescription. Champaign: Human Kinetics; 2006.

  39. Gabrielsen AM, Lund MB, Kongerud J, Viken KE, Roislien J, Hjelmesaeth J: The relationship between anthropometric measures, blood gases and ling function in morbidly obese white subjects.

    Obes Surg 2011, 21:485-491. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  40. Costa D, Sampaio LMM, Lorenzzo VAP, Jamami M, Damaso AR: Avaliação da força muscular respiratória e amplitudes torácicas e abdominais após a RFR em indivíduos obesos.

    Rev Latino-Am Enfermagem 2003, 1(2):156-60. OpenURL

  41. Pereira CAC: II Consenso Brasileiro de Espirometria.

    J Pneumol 2002, 28(3):S1-S82. OpenURL

  42. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.

    Eur Respir J Suppl 1994, 7(6):1197-8. OpenURL

  43. Magnani KL, Cataneo AJM: Respiratory muscle strength in obese individuals and influence of upper-body fat distribution.

    Med J 2007, 125(4):215-219. OpenURL

  44. Read DJC: A clinical method for assessing the ventilatory response to carbon dioxide.

    Australas Ann Med 1967, 16(1):20-32. PubMed Abstract OpenURL

  45. Murray WJ: A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

    leep 1991, 14(6):540-545. OpenURL

  46. Murray WJ: Reliability and factor analysis of Epowoth sleepiness scale.

    Sleep 1992, 15(4):376-81. PubMed Abstract OpenURL

  47. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP: Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome.

    Ann Intern Med 1999, 131(7):485-491. PubMed Abstract | Publisher Full Text OpenURL

  48. Rechtschaffen A, Kales A: A manual of standardized terminology: techniques and scoring system for sleep stages of human subjects. In Psychiatry and Clinical Neurosciences. Volume 55. Los Angeles: Brain Information Service/Brain Research Institute; 1968; 2001::305-310. PubMed Abstract | Publisher Full Text OpenURL

  49. Iber C, Ancoli-Israel S, Chesson A Jr, Quan S: The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Westchester: merican Academy of Sleep Medicine; 2007.

  50. American Academy of Sleep Medicine. The AASM Manual for the scoring of sleep and associated events

    Rules, terminology and technical especifications 2007. OpenURL

  51. Sundson M, Gustavsson S: Bariatric surgery.

    Clinics in dermatology 2004, 22:325-331. PubMed Abstract | Publisher Full Text OpenURL

  52. Karmali S, Stoklissa CJ, Sharma A, Stadnyk J, Christiansen S, Cottreau D, et al.: Bariatric surgery.

    Canadian Family Physician 2010, 56:873-879. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  53. Favretti F, Cadiere GB, Segato G, Busetto L, Loffredo A, Vertruyen M, Enzi G, Ciniato D, De Marchi F, Lise M: Bariatric Analysis and reporting outcome system (BAROS) applied to laparoscopic gastric banding patients.

    Obesity Surgery 1998, 8:500-504. PubMed Abstract | Publisher Full Text OpenURL

  54. Oria HE, Moorehead MK: Updated Bariatric Analysis and Reporting Outcome System (BAROS).

    Surgery for obesity and relate diseases 2009, 5:60-66. Publisher Full Text OpenURL

  55. Kleinbaum DG, Kupper LL, Morgestern H: Epidemiologic research Reinhold.

    Van Nostram 1983. OpenURL

  56. Pijl H: Obesity: evolution of symptom of affluence.

    The Jornal of Medicine 2011, 69(4):159-166. OpenURL

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2482/11/28/prepub